PMCF — Post-market clinical follow-up

The continuous process of proactively collecting and evaluating clinical data from a device already on the market, in order to confirm safety and performance across its expected lifetime, identify previously unknown side effects, and check that the benefit-risk position still holds. It is a planned activity, not a reaction to complaints.

Reference: MDR Annex XIV Part B

Previous
Previous

Placing on the market

Next
Next

PMPF — Post-market performance follow-up